Abstract
In this study, the preventative effects of Lactobacillus plantarum YS-3 (LP-YS3) on colitis were studied using an in vitro animal experiment. Oxazolone was administered to BALB/c mice to induce colitis, and the preventive effects of LP-YS3 were determined using serum- and tissue-related indexes. The mice treated with LP-YS3 showed a significant decrease (p < 0.05) in disease activity index for colitis by inhibiting colon shortening and increasing colon weight/length ratio. The application of LP-YS3 resulted in a significant reduction in myeloperoxidase, nitric oxide, and malondialdehyde activities and a decrease in glutathione activity (p < 0.05) in mouse colon tissues. LP-YS3 also significantly increased serum interleukin-2 and reduced interleukin-10 cytokines levels in mice (p < 0.05). Reverse transcription-polymerase chain reaction and western blot assays showed that LP-YS3 application resulted in a significant increase in neuronal nitric oxide synthase, endothelial nitric oxide synthase, c-Kit, and stem cell factor expressions and a decrease in inducible nitric oxide synthase, interleukin-8, and C-X-C motif chemokine receptor 2 expressions in mouse colonic tissues (p < 0.05). These findings indicate that LP-YS3 imparts preventative effects on oxazolone-induced colitis in mice.
Similar content being viewed by others
References
Stawowczyk E, Kawalec P (2017) Cost-effectiveness of biological treatment of ulcerative colitis—a systematic review. Prz Gastroenterol 12:90–97
Sun FM (2012) The pathogenesis of ulcerative colitis and therapeutic update. Guide China Med 10:445–447
Wei YB, Liu KR, Chen GZ (2015) Research progress of traditional Chinese in treatment of ulcerative colitis. J Liaoning Univ TCM 17:222–224
Cui HH, Chen CL, Sun Y, Liu YH, Wang YD, Zhang YD, Yang YJ, Pan LJ (2003) Changing of the flora and humoral immunofunction in patients with inflammatory bowel diseases. Chin J Microecol 15:151–155
Sun Y, Ding YQ (2009) Changes of intestinal flora and pathology in ulcerative colitis. Mod Digest Int 14:26–28
Linares DM, Gómez C, Renes E, Fresno JM, Tornadijo ME, Ross RP, Stanton C (2017) Lactic acid bacteria and bifidobacteria with potential to design natural biofunctional health-promoting dairy foods. Front Microbiol 8:846
Yu X, Li S, Yang D, Qiu L, Wu Y, Wang D, Shah NP, Xu F, Wei H (2016) A novel strain of Lactobacillus mucosae isolated from a Gaotian villager improves in vitro and in vivo antioxidant as well as biological properties in d-galactose-induced aging mice. J Dairy Sci 99:903–914
Del Carmen S, de Moreno de LeBlanc A, LeBlanc JG (2016) Development of a potential probiotic yoghurt using selected anti-inflammatory lactic acid bacteria for prevention of colitis and carcinogenesis in mice. J Appl Microbiol 121:821–830
Aubry C, Michon C, Chain F, Chvatchenko Y, Goffin L, Zimmerli SC, Leguin S, Langella P, Bermudez-Humaran L, Chatel JM (2015) Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model. Microb Cell Fact 14:176
Park JS, Joe I, Rhee PD, Jeong CS, Jeong G (2017) A lactic acid bacterium isolated from kimchi ameliorates intestinal inflammation in DSS-induced colitis. J Microbiol 55:304–310
Wu CS, Shu C, Li J, Qian Y, Suo HY (2012) The research progress and prospect of Yak yogurt lactic acid bacteria. Food Ind 2012:135–139
Wu CS, Li J, Qian Y, Suo HY (2012) Research progress of Yak milk and fermented Yak milk and their nutritional value. J Dairy Sci Technol 35:43–46
Qian Y, Suo HY, Du MY, Zhao X, Li J, Li GJ, Song JL, Liu ZH (2015) Preventive effect of Lactobacillus fermentum Lee on activated carbon-induced constipation in mice. Exp Ther Med 61:272–278
Zhao X, Wang Q, Li GJ, Chen F, Qian Y, Wang R (2014) In vitro antioxidant, anti-mutagenic, anti-cancer and anti-angiogenic effects of Chinese Bowl tea. J Funct Food 7:590–598
Zhao X, Kim SY, Park KY (2013) Bamboo salt has in vitro anticancer activity in HCT-116 cells and exerts anti-metastatic effects in vivo. J Med Food 16:9–19
Strober W, Fuss IJ, Blumberg RS (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20:495–549
Mustafa A, El-Medany A, Hagar HH, El-Medany G (2006) Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis. Pharmacol Res 53:324–330
Osman N, Adawi D, Ahrné S, Jeppsson B, Molin G (2008) Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)-induced colitis. Dig Dis Sci 53:2464–2473
Fiocchi C (2004) Inflammatory bowel disease: new insights into mechanisms of inflammation and increasingly customized approaches to diagnosis and therapy. Curr Opin Gastroenterol 20:309–310
Vallance BA, Dijkstra G, Qiu B, van der Waaij LA, van Goor H, Jansen PL, Mashimo H, Collins SM (2004) Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity. Am J Physiol Gastrointest Liver Physiol 287:G865–G874
Konturek PC, Brzozowski T, Engel M, Burnat G, Gaca P, Kwiecien S, Pajdo R, Konturek SJ (2009) Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. J Physiol Pharmacol 60:41–47
Li H, Lu ZH, Chen L, Lin L (2009) Expression of interstitial cells of Cajal and stem cell factors in mice colon with ulcerative colitis. Acta Univ Med Nanjing (Nat Sci) 29:648–651
Galli SJ, Tsai M, Wershil BK (1993) The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 142:965–974
Lee YS, Choi D, Kim NY, Yang S, Jung E, Hong M, Yang D, Lenz HJ, Hong YK (2014) CXCR2 inhibition enhances sulindac-mediated suppression of colon cancer development. Int J Cancer 135:232–237
Binder Gallimidi A, Nussbaum G, Hermano E, Weizman B, Meirovitz A, Vlodavsky I, Götte M, Elkin M (2017) Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma. PLoS ONE 12:e0174343
George AL, Bednarczyk R, Rajoria S, Hanly E, Suriano R, Mittelman A, Tiwari RK (2013) Abstract 1432: cXCL8 is a secretory inflammatory stimulus of the activated TME that modulates breast cancer phenotype. Cancer Res 73:1432–1432
Planagumà A, Domènech T, Pont M, Calama E, García-González V, López R, Aulí M, López M, Fonquerna S, Ramos I, de Alba J, Nueda A, Prats N, Segarra V, Miralpeix M, Lehner MD (2015) Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation. Pulm Pharmacol Ther 34:37–45
Acknowledgments
The present research was supported by the Program for Innovation Team Building at Institutions of Higher Education in Chongqing (CXTDX201601040), Chongqing Research Program of Basic Research and Frontier Technology (cstc2016jcyjA0339) and Research Project of Chongqing University of Education (KY2015TBZC), China.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Feng, X., Zhang, J., Qian, Y. et al. Preventative effects of Lactobacillus plantarum YS-3 on oxazolone-induced BALB/c colitis in mice. Appl Biol Chem 61, 355–363 (2018). https://doi.org/10.1007/s13765-018-0359-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13765-018-0359-3